Provided by Tiger Trade Technology Pte. Ltd.

Oculis

8.66
+0.16001.88%
Volume:452.01K
Turnover:3.88M
Market Cap:534.60M
PE:-5.05
High:8.75
Open:8.50
Low:8.37
Close:8.50
52wk High:34.48
52wk Low:8.30
Shares:61.73M
Float Shares:53.44M
Volume Ratio:1.21
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7151
EPS(LYR):-2.3888
ROE:-43.70%
ROA:-24.95%
PB:2.03
PE(LYR):-3.63

Loading ...

Earning Preview: Oculis revenue is expected to decrease by 3.77%, and institutional views are bullish

Earnings Agent
·
May 04

Oculis Nears Key Milestone as Phase 3 OCS-01 Eye Drop Trial in Diabetic Macular Edema Completes

TIPRANKS
·
May 03

Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

GlobeNewswire
·
May 01

Oculis to Present at Upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

GlobeNewswire
·
May 01

Orient Securities: Inference Expands New Frontiers for OCS, ASIC Liquid Cooling Becoming Standard

Stock News
·
Apr 29

Analysts Offer Insights on Healthcare Companies: MiMedx Group (MDXG) and Oculis Holding (OCS)

TIPRANKS
·
Apr 28

Oculis Advances Targeted Dry Eye Drug Licaminlimab Into Late-Stage Testing

TIPRANKS
·
Apr 26

Alphabet's Eighth-Generation TPU Launch Seen Benefiting Optical Modules, OCS, and Liquid Cooling Supply Chains

Stock News
·
Apr 24

Oculis Publishes Invitation to the Annual General Meeting

GlobeNewswire
·
Apr 22

Morning Briefing Highlights: Experience Economy in Full Swing, Service Consumption Enters New Phase

Stock News
·
Apr 21

Oculis Buy Rating Reiterated on De-Risked Phase 3 DIAMOND Program and Blockbuster Potential of Topical DME Therapy OCS-01

TIPRANKS
·
Apr 21

Oculis Holding Price Target Maintained With a $44.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 21

Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema

GlobeNewswire
·
Apr 20

Oculis Holding: Needham Conference Visibility Reinforces Buy Rating and Upside Potential

TIPRANKS
·
Apr 15